- Home
- JAKK vs TERN Comparison
JAKK vs TERN Comparison
Compare JAKK & TERN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- JAKK
- TERN
- Stock Information
- Founded
- JAKK 1995
- TERN 2017
- Country
- JAKK United States
- TERN United States
- Employees
- JAKK N/A
- TERN N/A
- Industry
- JAKK Recreational Games/Products/Toys
- TERN Biotechnology: Pharmaceutical Preparations
- Sector
- JAKK Consumer Discretionary
- TERN Health Care
- Exchange
- JAKK Nasdaq
- TERN Nasdaq
- Market Cap
- JAKK 374.4M
- TERN 355.9M
- IPO Year
- JAKK 1996
- TERN 2021
- Fundamental
- Price
- JAKK $30.01
- TERN $4.01
- Analyst Decision
- JAKK Strong Buy
- TERN Buy
- Analyst Count
- JAKK 5
- TERN 5
- Target Price
- JAKK $41.00
- TERN $18.30
- AVG Volume (30 Days)
- JAKK 154.8K
- TERN 1.7M
- Earning Date
- JAKK 02-20-2025
- TERN 03-13-2025
- Dividend Yield
- JAKK N/A
- TERN N/A
- EPS Growth
- JAKK N/A
- TERN N/A
- EPS
- JAKK 3.14
- TERN N/A
- Revenue
- JAKK $691,042,000.00
- TERN N/A
- Revenue This Year
- JAKK N/A
- TERN N/A
- Revenue Next Year
- JAKK $3.62
- TERN N/A
- P/E Ratio
- JAKK $9.35
- TERN N/A
- Revenue Growth
- JAKK N/A
- TERN N/A
- 52 Week Low
- JAKK $17.06
- TERN $3.96
- 52 Week High
- JAKK $36.35
- TERN $11.40
- Technical
- Relative Strength Index (RSI)
- JAKK 43.51
- TERN 33.73
- Support Level
- JAKK $33.70
- TERN $4.01
- Resistance Level
- JAKK $35.79
- TERN $4.24
- Average True Range (ATR)
- JAKK 1.17
- TERN 0.21
- MACD
- JAKK -0.09
- TERN 0.01
- Stochastic Oscillator
- JAKK 22.66
- TERN 5.59
About JAKK JAKKS Pacific Inc.
Jakks Pacific Inc is a multi-brand toy company that designs, produces, markets, and distributes toys and related products, consumables, and related products, electronics and related products, kids' indoor and outdoor furniture, and other consumer products. Its products offering include Traditional toys and electronics such as Action figures, Toy vehicles, Dolls and accessories, Ride-on toys, Toys for pets, and others.
About TERN Terns Pharmaceuticals Inc.
Terns Pharmaceuticals Inc is a clinical-stage biopharmaceutical company. The company is developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, NASH, and other chronic liver diseases.